다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Frontiers in microbiology, v.8, 2017년, pp.563 -
Dahiya, Dinesh K. (Advanced Milk Testing Research Laboratory, Post Graduate Institute of Veterinary Education and Research –) , Renuka (Rajasthan University of Veterinary and Animal Sciences at Bikaner Jaipur, India) , Puniya, Monica (Department of Biochemistry, Basic Medical Science, South Campus, Panjab University Chandigarh, India) , Shandilya, Umesh K. (Food Safety Management System Division, Food Safety and Standards Authority of India New Delhi, India) , Dhewa, Tejpal (Animal Biotechnology Division, National Bureau of Animal Genetic Resources Karnal, India) , Kumar, Nikhil (Department of Nutrition Biology, Central University of Haryana Mahendergarh, India) , Kumar, Sanjeev (Department of Life Sciences, Shri Venkateshwara University JP Nagar, India) , Puniya, Anil K. (Department of Life Science, Central Assam University Silchar, India) , Shukla, Pratyoosh (College of Dairy Scie)
AI-Helper
In the present world scenario, obesity has almost attained the level of a pandemic and is progressing at a rapid rate. This disease is the mother of all other metabolic disorders, which apart from placing an added financial burden on the concerned patient also has a negative impact on his/her well-b...
Aagaard K. Ma J. Antony K. M. Ganu R. Petrosino J. Versalovic J. ( 2014 ). The placenta harbors a unique microbiome. Sci. Trans. Med. 6 237 ra265. 10.1126/scitranslmed.3008599
Alard J. Lehrter V. Rhimi M. Mangin I. Peucelle V. Abraham A. L. ( 2016 ). Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ. Microbiol. 18 1484 – 1497 . 10.1111/1462-2920.13181 26689997
An H. M. Park S. Y. Lee D. K. Kim J. R. Cha M. K. Lee S. W. ( 2011 ). Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 10 : 116 10.1186/1476-511X-10-116
Angin Y. Beauloye C. Horman S. Bertrand L. ( 2016 ). “Regulation of carbohydrate metabolism, lipid metabolism, and protein metabolism by AMPK,” in AMP-Activated Protein Kinase , ( Berlin : Springer ), 23 – 43 . 10.1007/978-3-319-43589-3_2
Armougom F. Henry M. Vialettes B. Raccah D. Raoult D. ( 2009 ). Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE 4 : e7125 10.1371/journal.pone.0007125
Aron-Wisnewsky J. Gaborit B. Dutour A. Clement K. ( 2013 ). Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin. Microbiol. Infect 19 338 – 348 . 10.1111/1469-0691.12140 23452163
Arora T. Singh S. Sharma R. K. ( 2013 ). Probiotics: interaction with gut microbiome and antiobesity potential. Nutrition 29 591 – 596 . 10.1016/j.nut.2012.07.017 23287068
Arumugam M. Raes J. Pelletier E. Le Paslier D. Yamada T. Mende D. R. ( 2011 ). Enterotypes of the human gut microbiome. Nature 473 174 – 180 . 10.1038/nature09944 21508958
Bäckhed F. Ding H. Wang T. Hooper L. V. Koh G. Y. Nagy A. ( 2004 ). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101 15718 – 15723 . 10.1073/pnas.0407076101 15505215
Bäckhed F. Manchester J. K. Semenkovich C. F. Gordon J. I. ( 2007 ). Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U.S.A. 104 979 – 984 . 10.1073/pnas.0605374104 17210919
Balamurugan R. George G. Kabeerdoss J. Hepsiba J. Chandragunasekaran A. M. Ramakrishna B. S. ( 2010 ). Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br. J. Nutr. 103 335 – 338 . 10.1017/S0007114509992182 19849869
Boulangé C. L. Neves A. L. Chilloux J. Nicholson J. K. Dumas M.-E. ( 2016 ). Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 8 : 42 10.1186/s13073-016-0303-2
Brown A. J. Goldsworthy S. M. Barnes A. A. Eilert M. M. Tcheang L. Daniels D. ( 2003 ). The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278 11312 – 11319 . 10.1074/jbc.M211609200 12496283
Cani P. D. Amar J. Iglesias M. A. Poggi M. Knauf C. Bastelica D. ( 2007a ). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes Metab. Res. Rev. 56 1761 – 1772 . 10.2337/db06-1491
Cani P. D. Bibiloni R. Knauf C. Waget A. Neyrinck A. M. Delzenne N. M. ( 2008 ). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes Metab. Res. Rev. 57 1470 – 1481 . 10.2337/db07-1403
Cani P. D. Dewever C. Delzenne N. M. ( 2004 ). Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br. J. Nutr. 92 521 – 526 . 10.1079/BJN20041225 15469657
Cani P. D. Everard A. Duparc T. ( 2013 ). Gut microbiota, enteroendocrine functions and metabolism. Curr. Opin. Pharmacol. 13 935 – 940 . 10.1016/j.coph.2013.09.008 24075718
Cani P. D. Hoste S. Guiot Y. Delzenne N. M. ( 2007b ). Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br. J. Nutr. 98 32 – 37 . 17367575
Cani P. D. Joly E. Horsmans Y. Delzenne N. ( 2006a ). Oligofructose promotes satiety in healthy human: a pilot study. Eur. J. Clin. Nutr. 60 567 – 572 . 16340949
Cani P. D. Knauf C. Iglesias M. A. Drucker D. J. Delzenne N. M. Burcelin R. ( 2006b ). Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes Metab. Res. Rev. 55 1484 – 1490 .
Cani P. D. Lecourt E. Dewulf E. M. Sohet F. M. Pachikian B. D. Naslain D. ( 2009a ). Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90 1236 – 1243 . 10.3945/ajcn.2009.28095 19776140
Cani P. D. Neyrinck A. Fava F. Knauf C. Burcelin R. Tuohy K. ( 2007c ). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50 2374 – 2383 . 17823788
Cani P. D. Possemiers S. Van de Wiele T. Guiot Y. Everard A. Rottier O. ( 2009b ). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 1091 – 1103 . 10.1136/gut.2008.165886 19240062
Chiang J. Y. ( 2009 ). Bile acids: regulation of synthesis. J. Lipid Res. 50 1955 – 1966 . 10.1194/jlr.R900010-JLR200 19346330
Cho I. Yamanishi S. Cox L. Methé B. A. Zavadil J. Li K. ( 2012 ). Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488 621 – 626 . 10.1038/nature11400 22914093
Clarke S. F. Murphy E. F. O’Sullivan O. Ross R. P. O’Toole P. W. Shanahan F. ( 2013 ). Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS ONE 8 : e65790 10.1371/journal.pone.0065790
Cotillard A. Kennedy S. P. Kong L. C. Prifti E. Pons N. Le Chatelier E. ( 2013 ). Dietary intervention impact on gut microbial gene richness. Nature 500 585 – 588 . 10.1038/nature12480 23985875
Cox L. M. Yamanishi S. Sohn J. Alekseyenko A. V. Leung J. M. Cho I. ( 2014 ). Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158 705 – 721 . 10.1016/j.cell.2014.05.052 25126780
da Silva S. T. dos Santos C. A. Bressan J. ( 2013 ). Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics. Nutr. Hosp. 28 1039 – 1048 . 10.3305/nh.2013.28.4.6525 23889619
Dahiya D. K. Puniya A. K. ( 2015 ). Evaluation of survival, free radical scavenging and human enterocyte adherence potential of Lactobacilli with anti-obesity and anti-inflammatory CLA isomer-producing attributes. J. Food Process. Preserv. 36 2866 – 2877 . 10.1111/jfpp.12538
Dahiya D. K. Puniya A. K. ( 2017 ). Isolation, molecular characterization and screening of indigenous lactobacilli for their abilities to produce bioactive conjugated linoleic acid (CLA). J. Food Sci. Technol. 54 792 – 801 . 10.1007/s13197-017-2523-x 28298694
Dao M. C. Everard A. Aron-Wisnewsky J. Sokolovska N. Prifti E. Verger E. O. ( 2016 ). Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65 426 – 436 . 10.1136/gutjnl-2014-308778 26100928
Davis J. E. Gabler N. K. Walker-Daniels J. Spurlock M. E. ( 2008 ). Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 16 1248 – 1255 . 10.1038/oby.2008.210 18421279
De Silva A. Bloom S. R. ( 2012 ). Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver 6 10 – 20 . 10.5009/gnl.2012.6.1.10 22375166
Dewulf E. M. Cani P. D. Claus S. P. Fuentes S. Puylaert P. G. Neyrinck A. M. ( 2012 ). Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62 1112 – 1121 . 10.1136/gutjnl-2012-303304 23135760
Dray C. Knauf C. Daviaud D. Waget A. Boucher J. Buléon M. ( 2008 ). Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 8 437 – 445 . 10.1016/j.cmet.2008.10.003 19046574
Druart C. Neyrinck A. M. Dewulf E. M. De Backer F. C. Possemiers S. Van de Wiele T. ( 2013 ). Implication of fermentable carbohydrates targeting the gut microbiota on conjugated linoleic acid production in high-fat-fed mice. Br. J. Nutr. 110 998 – 1011 . 10.1017/S0007114513000123 23507010
Duncan S. H. Belenguer A. Holtrop G. Johnstone A. M. Flint H. J. Lobley G. E. ( 2007 ). Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 73 1073 – 1078 . 10.1128/AEM.02340-06 17189447
Duncan S. H. Louis P. Thomson J. M. Flint H. J. ( 2009 ). The role of pH in determining the species composition of the human colonic microbiota. Environ. Microbiol. 11 2112 – 2222 . 10.1111/j.1462-2920.2009.01931.x 19397676
Dutton S. Trayhurn P. ( 2008 ). Regulation of angiopoietin-like protein 4/fasting-induced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. Br. J. Nutr. 100 18 – 26 . 10.1017/S0007114507882961 18081944
Eckburg P. B. Bik E. M. Bernstein C. N. Purdom E. Dethlefsen L. Sargent M. ( 2005 ). Diversity of the human intestinal microbial flora. Science 308 1635 – 1638 . 10.1126/science.1110591 15831718
Everard A. Belzer C. Geurts L. Ouwerkerk J. P. Druart C. Bindels L. B. ( 2013 ). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 110 9066 – 9071 . 10.1073/pnas.1219451110 23671105
Everard A. Lazarevic V. Derrien M. Girard M. Muccioli G. G. Neyrinck A. M. ( 2011 ). Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes Metab. Res. Rev. 60 2775 – 2786 . 10.2337/db11-0227
Everard A. Lazarevic V. Gaïa N. Johansson M. Ståhlman M. Backhed F. ( 2014 ). Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 8 2116 – 2130 . 10.1038/ismej.2014.45 24694712
Feng J. Tang H. Li M. Pang X. Wang L. Zhang M. ( 2014 ). The abundance of fecal Faecalibacterium prausnitzii in relation to obesity and gender in Chinese adults. Arch. Microbiol. 196 73 – 77 . 10.1007/s00203-013-0942-2 24292154
Fleissner C. K. Huebel N. El-Bary M. M. A. Loh G. Klaus S. Blaut M. ( 2010 ). Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104 919 – 929 . 10.1017/S0007114510001303 20441670
Franzosa E. A. Huang K. Meadow J. F. Gevers D. Lemon K. P. Bohannan B. J. ( 2015 ). Identifying personal microbiomes using metagenomic codes. Proc. Natl. Acad. Sci. U.S.A. 112 E2930 – E2938 . 10.1073/pnas.1423854112 25964341
Gad G. F. M. Abdel-Hamid A. M. Farag Z. S. H. ( 2014 ). Antibiotic resistance in lactic acid bacteria isolated from some pharmaceutical and dairy products. Braz. J. Microbiol. 45 25 – 33 . 10.1590/S1517-83822014000100005 24948910
Gérard P. ( 2016 ). Gut microbiota and obesity. Cell. Mol. Life Sci. 73 147 – 162 . 10.1007/s00018-015-2061-5 26459447
Geurts L. Lazarevic V. Derrien M. Everard A. Van Roye M. Knauf C. ( 2011 ). Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front. Microbiol. 2 : 149 10.3389/fmicb.2011.00149
Gibson G. R. Probert H. M. Van Loo J. Rastall R. A. Roberfroid M. B. ( 2004 ). Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17 259 – 275 . 10.1079/NRR200479 19079930
Hotamisligil G. S. ( 2006 ). Inflammation and metabolic disorders. Nature 444 860 – 867 . 10.1038/nature05485 17167474
Joossens M. Huys G. Van Steen K. Cnockaert M. Vermeire S. Rutgeerts P. ( 2011 ). High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake. FEMS Microbiol. Ecol. 75 343 – 349 . 10.1111/j.1574-6941.2010.01008.x 21133959
Karra E. Chandarana K. Batterham R. L. ( 2009 ). The role of peptide YY in appetite regulation and obesity. J. Physiol. 587 19 – 25 . 10.1113/jphysiol.2008.164269 19064614
Kasubuchi M. Hasegawa S. Hiramatsu T. Ichimura A. Kimura I. ( 2015 ). Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7 2839 – 2849 . 10.3390/nu7042839 25875123
Kim J. Yang G. Ha J. ( 2017 ). Targeting of AMP-activated protein kinase: prospects for computer-aided drug design. Expert Opin. Drug Dis. 12 47 – 59 . 10.1080/17460441.2017.1255194
Kim K.-A. Jeong J.-J. Kim D.-H. ( 2015 ). Lactobacillus brevis OK56 ameliorates high-fat diet-induced obesity in mice by inhibiting NF-κB activation and gut microbial LPS production. J. Funct. Foods 13 183 – 191 . 10.1016/j.jff.2014.12.045
Kimura I. Ozawa K. Inoue D. Imamura T. Kimura K. Maeda T. ( 2013 ). The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4 1829 10.1038/ncomms2852
Knights D. Ward T. L. McKinlay C. E. Miller H. Gonzalez A. McDonald D. ( 2014 ). Rethinking “enterotypes”. Cell Host Microbe 16 433 – 437 . 10.1016/j.chom.2014.09.013 25299329
Koenig J. E. Spor A. Scalfone N. Fricker A. D. Stombaugh J. Knight R. ( 2011 ). Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1) , 4578 – 4585 . 10.1073/pnas.1000081107 20668239
Koh A. De Vadder F. Kovatcheva-Datchary P. Bäckhed F. ( 2016 ). From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165 1332 – 1345 . 10.1016/j.cell.2016.05.041 27259147
Kopelman P. ( 2007 ). Health risks associated with overweight and obesity. Obes. Rev. 8 13 – 17 . 10.1111/j.1467-789X.2007.00311.x 17316295
Koren O. Knights D. Gonzalez A. Waldron L. Segata N. Knight R. ( 2013 ). A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput. Biol. 9 : e1002863 10.1371/journal.pcbi.1002863
Larsen N. Vogensen F. K. Gøbel R. J. Michaelsen K. F. Forssten S. D. Lahtinen S. J. ( 2013 ). Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin. Nutr. 32 935 – 940 . 10.1016/j.clnu.2013.02.007 23510724
Le Chatelier E. Nielsen T. Qin J. Prifti E. Hildebrand F. Falony G. ( 2013 ). Richness of human gut microbiome correlates with metabolic markers. Nature 500 541 – 546 . 10.1038/nature12506 23985870
Le Poul E. Loison C. Struyf S. Springael J.-Y. Lannoy V. Decobecq M.-E. ( 2003 ). Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278 25481 – 25489 . 10.1074/jbc.M301403200 12711604
Lee S. J. Bose S. Seo J.-G. Chung W.-S. Lim C.-Y. Kim H. ( 2014 ). The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial. Clin. Nutr. 33 973 – 981 . 10.1016/j.clnu.2013.12.006 24411490
Letran S. E. Lee S.-J. Atif S. M. Flores-Langarica A. Uematsu S. Akira S. ( 2011 ). TLR5-deficient mice lack basal inflammatory and metabolic defects but exhibit impaired CD4 T cell responses to a flagellated pathogen. J. Immunol. 186 5406 – 5412 . 10.4049/jimmunol.1003576 21451112
Leung C. Rivera L. Furness J. B. Angus P. W. ( 2016 ). The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13 412 – 425 . 10.1038/nrgastro.2016.85 27273168
Ley R. E. Bäckhed F. Turnbaugh P. Lozupone C. A. Knight R. D. Gordon J. I. ( 2005 ). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102 11070 – 11075 . 10.1073/pnas.0504978102 16033867
Ley R. E. Turnbaugh P. J. Klein S. Gordon J. I. ( 2006 ). Microbial ecology: human gut microbes associated with obesity. Nature 444 1022 – 1023 . 10.1038/4441022a 17183309
Lim S.-M. Jeong J.-J. Woo K. H. Han M. J. Kim D.-H. ( 2016 ). Lactobacillus sakei OK67 ameliorates high-fat diet–induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutr. Res. 36 337 – 348 . 10.1016/j.nutres.2015.12.001 27001279
Louis P. Flint H. J. ( 2009 ). Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294 1 – 8 . 10.1111/j.1574-6968.2009.01514.x 19222573
Luna R. A. Foster J. A. ( 2015 ). Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Curr. Opin. Biotechnol. 32 35 – 41 . 10.1016/j.copbio.2014.10.007 25448230
Luoto R. Kalliomäki M. Laitinen K. Isolauri E. ( 2010 ). The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int. J. Obes. 34 1531 – 1537 . 10.1038/ijo.2010.50
Mackie K. ( 2008 ). Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol. 20 10 – 14 . 10.1111/j.1365-2826.2008.01671.x 18426493
Maenhaut N. Van de Voorde J. ( 2011 ). Regulation of vascular tone by adipocytes. BMC Med. 9 : 25 10.1186/1741-7015-9-25
Marteau P. Seksik P. ( 2004 ). Tolerance of probiotics and prebiotics. J. Clin. Gastroenterol. 38 S67 – S69 . 10.1097/01.mcg.0000128929.37156.a7 15220662
Medzhitov R. ( 2001 ). Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1 135 – 145 . 10.1038/35100529 11905821
Million M. Angelakis E. Paul M. Armougom F. Leibovici L. Raoult D. ( 2012a ). Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 53 100 – 108 . 10.1016/j.micpath.2012.05.007 22634320
Million M. Maraninchi M. Henry M. Armougom F. Richet H. Carrieri P. ( 2012b ). Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii . Int. J. Obes. 36 817 – 825 . 10.1038/ijo.2011.153
Miquel S. Martín R. Rossi O. Bermúdez-Humarán L. G. Chatel J. M. Sokol H. ( 2013 ). Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 16 255 – 261 . 10.1016/j.mib.2013.06.003 23831042
Muccioli G. G. Naslain D. Bäckhed F. Reigstad C. S. Lambert D. M. Delzenne N. M. ( 2010 ). The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 6 392 10.1038/msb.2010.46
Mueller N. T. Whyatt R. Hoepner L. Oberfield S. Dominguez-Bello M. G. Widen E. ( 2014 ). Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int. J. Obes. 39 665 – 670 . 10.1038/ijo.2014.180
Murphy E. F. Cotter P. D. Hogan A. O’sullivan O. Joyce A. Fouhy F. ( 2013 ). Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62 220 – 226 . 10.1136/gutjnl-2011-300705 22345653
Neyrinck A. M. Possemiers S. Druart C. Van de Wiele T. De Backer F. Cani P. D. ( 2011 ). Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides / Prevotella in diet-induced obese mice. PLoS ONE 6 : e20944 10.1371/journal.pone.0020944
Nikolopoulou A. Kadoglou N. P. ( 2012 ). Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev. Cardiovasc. Ther. 10 933 – 939 . 10.1586/erc.12.74 22908926
Nøhr M. K. Pedersen M. H. Gille A. Egerod K. L. Engelstoft M. S. Husted A. S. ( 2013 ). GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154 3552 – 3564 . 10.1210/en.2013-1142 23885020
Ouchi N. Parker J. L. Lugus J. J. Walsh K. ( 2011 ). Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11 85 – 97 . 10.1038/nri2921 21252989
Park D. Y. Ahn Y. T. Park S. H. Huh C. S. Yoo S. R. Yu R. ( 2013 ). Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS ONE 8 : e59470 10.1371/journal.pone.0059470
Park S. Ji Y. Jung H.-Y. Park H. Kang J. Choi S.-H. ( 2017 ). Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model. Appl. Microbiol. Biotechnol. 101 1605 – 1614 . 10.1007/s00253-016-7953-2 27858139
Parnell J. A. Reimer R. A. ( 2009 ). Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89 1751 – 1759 . 10.3945/ajcn.2009.27465 19386741
Perez-Chanona E. Trinchieri G. ( 2016 ). The role of microbiota in cancer therapy. Curr. Opin. Immunol. 39 75 – 81 . 10.1016/j.coi.2016.01.003 26820225
Peterson C. Sharma V. Elmén L. Peterson S. ( 2015 ). Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin. Exp. Immunol. 179 363 – 377 . 10.1111/cei.12474 25345825
Podolsky S. H. ( 2017 ). Historical perspective on the rise and fall and rise of antibiotics and human weight gainhistorical perspective on antibiotics and human weight gain. Ann. Intern. Med. 166 133 – 138 . 10.7326/M16-1855 28114473
Qin J. Li R. Raes J. Arumugam M. Burgdorf K. S. Manichanh C. ( 2010 ). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 59 – 65 . 10.1038/nature08821 20203603
Quigley E. M. ( 2011 ). Gut microbiota and the role of probiotics in therapy. Curr. Opin. Pharmacol. 11 593 – 603 . 10.1016/j.coph.2011.09.010 21996283
Rajkumar H. Kumar M. Das N. Kumar S. N. Challa H. R. Nagpal R. ( 2015 ). Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J. Cardiovasc. Pharmacol. Ther. 20 289 – 298 . 10.1177/1074248414555004 25331262
Ramirez-Farias C. Slezak K. Fuller Z. Duncan A. Holtrop G. Louis P. ( 2009 ). Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii . Br. J. Nutr. 101 541 – 550 . 10.1017/S0007114508019880 18590586
Rather S. A. Pothuraju R. Sharma R. K. De S. Mir N. A. Jangra S. ( 2014 ). Anti-obesity effect of feeding probiotic dahi containing Lactobacillus casei NCDC 19 in high fat diet-induced obese mice. Int. J. Dairy Technol. 67 504 – 509 . 10.1111/1471-0307.12154
Regard J. B. Sato I. T. Coughlin S. R. ( 2008 ). Anatomical profiling of G protein-coupled receptor expression. Cell 135 561 – 571 . 10.1016/j.cell.2008.08.040 18984166
Remely M. Hippe B. Zanner J. Aumueller E. Brath H. Haslberger A. G. ( 2016 ). Gut microbiota of obese, type 2 diabetic individuals is enriched in Faecalibacterium prausnitzii , Akkermansia muciniphila and Peptostreptococcus anaerobius after weight loss. Endocr. Metab. Immune Disord. Drug Targets 16 99 – 106 . 10.2174/1871530316666160831093813
Respondek F. Gerard P. Bossis M. Boschat L. Bruneau A. Rabot S. ( 2013 ). Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice. PLoS ONE 8 : e71026 10.1371/journal.pone.0071026
Ridlon J. M. Kang D. J. Hylemon P. B. Bajaj J. S. ( 2014 ). Bile acids and the gut microbiome. Curr. Opin. Gastroenterol. 30 332 – 338 . 10.1097/MOG.0000000000000057 24625896
Riva A. Borgo F. Lassandro C. Verduci E. Morace G. Borghi E. ( 2017 ). Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations. Environ. Microbiol. 19 95 – 105 . 10.1111/1462-2920.13463 27450202
Rosenbaum M. Knight R. Leibel R. L. ( 2015 ). The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol. Metab. 26 493 – 501 . 10.1016/j.tem.2015.07.002 26257300
Salazar N. Dewulf E. M. Neyrinck A. M. Bindels L. B. Cani P. D. Mahillon J. ( 2015 ). Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin. Nutr. 34 501 – 507 . 10.1016/j.clnu.2014.06.001 24969566
Sanders M. E. ( 2008 ). Probiotics: definition, sources, selection, and uses. Clin. Infect. Dis. 46(Suppl. 2) , S58 – S61 . 10.1086/523341 18181724
Sanz Y. Rastmanesh R. Agostonic C. ( 2013 ). Understanding the role of gut microbes and probiotics in obesity: how far are we? Pharmacol. Res. 69 144 – 155 . 10.1016/j.phrs.2012.10.021 23147032
Sayin S. I. Wahlström A. Felin J. Jäntti S. Marschall H.-U. Bamberg K. ( 2013 ). Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17 225 – 235 . 10.1016/j.cmet.2013.01.003 23395169
Schneeberger M. Everard A. Gómez-Valadés A. G. Matamoros S. Ramírez S. Delzenne N. M. ( 2015 ). Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 5 : 16643 10.1038/srep16643
Singh S. Sharma R. Malhotra S. Pothuraju R. Shandilya U. ( 2016 ). Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocintreated rats. Benef. Microbes 10.3920/BM2016.0090 [Epub ahead of print] .
Sommer F. Bäckhed F. ( 2013 ). The gut microbiota—masters of host development and physiology. Nat. Rev. Microbiol. 11 227 – 238 . 10.1038/nrmicro2974 23435359
Stanton C. Ross R. P. Fitzgerald G. F. Van Sinderen D. ( 2005 ). Fermented functional foods based on probiotics and their biogenic metabolites. Curr. Opin. Biotechnol. 16 198 – 203 . 10.1038/nrmicro2974 15831387
Steinert R. Beglinger C. Langhans W. ( 2016 ). Intestinal GLP-1 and satiation: from man to rodents and back. Int. J. Obes. 40 198 – 205 . 10.1038/ijo.2015.172
Swann J. R. Want E. J. Geier F. M. Spagou K. Wilson I. D. Sidaway J. E. ( 2011 ). Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1) , 4523 – 4530 . 10.1073/pnas.1006734107 20837534
Swinburn B. A. Sacks G. Hall K. D. McPherson K. Finegood D. T. Moodie M. L. ( 2011 ). The global obesity pandemic: shaped by global drivers and local environments. Lancet 378 804 – 814 . 10.1016/S0140-6736(11)60813-1 21872749
Tarini J. Wolever T. M. ( 2010 ). The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl. Physiol. Nutr. Metab. 35 9 – 16 . 10.1139/H09-119 20130660
Tolhurst G. Heffron H. Lam Y. S. Parker H. E. Habib A. M. Diakogiannaki E. ( 2012 ). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein–coupled receptor FFAR2. Diabetes Metab. Res. Rev. 61 364 – 371 . 10.2337/db11-1019
Toral M. Gómez-Guzmán M. Jiménez R. Romero M. Sánchez M. Utrilla M. P. ( 2014 ). The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin. Sci. 127 33 – 45 . 10.1042/CS20130339 24410749
Tsai Y.-T. Cheng P.-C. Pan T.-M. ( 2014 ). Anti-obesity effects of gut microbiota are associated with lactic acid bacteria. Appl. Microbiol. Biotechnol. 98 1 – 10 . 10.1042/CS20130339 24232731
Turnbaugh P. J. Ley R. E. Mahowald M. A. Magrini V. Mardis E. R. Gordon J. I. ( 2006 ). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 1027 – 1131 . 10.1007/s00253-013-5346-3 17183312
Turta O. Rautava S. ( 2016 ). Antibiotics, obesity and the link to microbes-what are we doing to our children? BMC Med. 14 : 57 10.1186/s12916-016-0605-7
Velagapudi V. R. Hezaveh R. Reigstad C. S. Gopalacharyulu P. Yetukuri L. Islam S. ( 2010 ). The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 51 1101 – 1112 . 10.1194/jlr.M002774 20040631
Vijay-Kumar M. Aitken J. D. Carvalho F. A. Cullender T. C. Mwangi S. Srinivasan S. ( 2010 ). Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 228 – 231 . 10.1126/science.1179721 20203013
Villena J. Kitazawa H. ( 2014 ). Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front. Immunol. 4 : 512 10.3389/fimmu.2013.00512
Vucenik I. Stains J. P. ( 2012 ). Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann. N. Y. Acad. Sci. 1271 37 – 43 . 10.1111/j.1749-6632.2012.06750.x 23050962
Wang H. Eckel R. H. ( 2009 ). Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 297 E271 – E288 . 10.1152/ajpendo.90920.2008 19318514
Wang Y. C. McPherson K. Marsh T. Gortmaker S. L. Brown M. ( 2011 ). Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378 815 – 825 . 10.1016/S0140-6736(11)60814-3 21872750
Wang Z. Xiao G. Yao Y. Guo S. Lu K. Sheng Z. ( 2006 ). The role of bifidobacteria in gut barrier function after thermal injury in rats. J. Trauma Acute Care Surg. 61 650 – 657 . 10.1016/S0140-6736(11)60814-3
Withrow D. Alter D. ( 2011 ). The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes. Rev. 12 131 – 141 . 10.1111/j.1467-789X.2009.00712.x 20122135
Xiong Y. Miyamoto N. Shibata K. Valasek M. A. Motoike T. Kedzierski R. M. ( 2004 ). Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. U.S.A. 101 1045 – 1050 . 10.1111/j.1467-789X.2009.00712.x 14722361
Yadav H. Lee J. H. Lloyd J. Walter P. Rane S. G. ( 2013 ). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J. Biol. Chem. 288 25088 – 25097 . 10.1074/jbc.M113.452516 23836895
Yadav R. Singh P. K. Puniya A. K. Shukla P. ( 2016a ). Catalytic interactions andmolecular docking of bile salt hydrolase (BSH) from L. plantarum RYPR1 and itsprebiotic utilization. Front. Microbiol. 7 : 2116 10.3389/fmicb.2016.02116
Yadav R. Singh P. K. Shukla P. ( 2016b ). Metabolic engineering for probiotics and their genome-wide expression profiling. Curr. Protein Pept. Sci. 10.2174/1389203718666161111130157 [Epub ahead of print] .
Yin Y.-N. Yu Q.-F. Fu N. Liu X.-W. Lu F.-G. ( 2010 ). Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J. Gastroenterol. 16 3394 – 3401 . 10.3748/wjg.v16.i27.3394 20632441
Zaibi M. S. Stocker C. J. O’Dowd J. Davies A. Bellahcene M. Cawthorne M. A. ( 2010 ). Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett. 584 2381 – 2386 . 10.1016/j.febslet.2010.04.027 20399779
Zhou J. Martin R. J. Tulley R. T. Raggio A. M. McCutcheon K. L. Shen L. ( 2008 ). Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 295 E1160 – E1166 . 10.1152/ajpendo.90637.2008 18796545
Zimmer J. Lange B. Frick J.-S. Sauer H. Zimmermann K. Schwiertz A. ( 2012 ). A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur. J. Clin. Nutr. 66 53 – 60 . 10.1038/ejcn.2011.141 21811294
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.